Elizabeth Prewitt’s practice focuses on international cartel and criminal matters, government and internal investigations, and complex litigation. She is a co-chair of the firm’s antitrust practice and a member of its Executive Committee.
For 16 years, Elizabeth was a trial lawyer for the US Department of Justice and served as an Assistant Chief in the Antitrust Division from 2012 – 2014. The American Lawyer named Elizabeth as one of 25 “star laterals” of 2015 on her move to Hughes Hubbard & Reed. She has since been recommended by Global Competition Review, Expert Guides, The Legal 500, recognizing Elizabeth for being ‘smart and tenacious’, and Chambers USA, noting that sources describe her as ‘very smart, very strategic and very user-friendly.’
At the DOJ, Elizabeth led several large-scale investigations into bribery, money laundering, major fraud, tax and antitrust violations, and was the Division’s lead prosecutor investigating global financial institutions for alleged rigging of benchmark interest rates (LIBOR), and the alleged rigging of certain foreign currency exchange rates (Forex). She also served as a Visiting International Enforcer to the European Commission’s Directorate-General for Competition (DGCOMP) in Brussels in March 2014.
Elizabeth defends companies, financial institutions, and individuals in enforcement actions, prosecutions, and investigations initiated by federal and state agencies and departments, including the Securities and Exchange Commission (SEC), Department of Justice (DOJ), United States Attorneys and grand juries, Commodity Futures Trading Commission (CFTC), and State Attorneys General. She has handled cross-border matters involving overseas regulators and enforcers such as the Financial Conduct Authority (FCA), Serious Fraud Office (SFO), Competition and Markets Authority (CMA), and the European Commission (DGCOMP).
Elizabeth has substantial first-chair jury trial experience, and was twice the recipient of an Attorney General’s Award for Distinguished Service (the DOJ’s second-highest award) and twice the recipient of the Assistant Attorney General’s Award.
She served as an instructor on cartel enforcement and investigative techniques at the DOJ and for competition authorities in Europe and Asia, and is frequently an invited speaker on topics including cross-border investigations, enforcement in the financial services industry, anti-corruption, e.g., the Foreign Corrupt Practices Act (FCPA), anti-money laundering (AML) and compliance.
Member, Hughes Hubbard & Reed Executive Committee
Vice chair, American Bar Association (ABA) Antitrust Law Section, Insurance and Financial Services Committee
Secretary, New York City Bar Association, Antitrust and Trade Regulation Committee
Advisory board, ABA Antitrust Law Section, Compliance & Ethics Committee
Advisory board, ABA Antitrust Law Section, Cartel & Criminal Practice Committee
Member, International Bar Association, Cartels Working Group
Member, US Council for International Business Competition Committee
Fellow, David Rockefeller Fellows Program of the Partnership for New York City, 2016-2017
Fellow, American Bar Foundation
Prewitt, Elizabeth, Dina Hoffer and Brittany Cohen, “Updated DOJ Leniency Program FAQs: Implications for Immunity Protections,” American Bar Association, The Exchange, Insurance and Financial Services Developments, Section of Antitrust Law (Spring 2017)
Prewitt, Elizabeth, Brittany Cohen and Dina Hoffer, “The Stakes Are High For Those Caught In No-Poach Probes,” Law360 (June 20, 2017)
Prewitt, Elizabeth, Marc Weinstein and Jeffrey Goldberg, “Questions Following Prevezon Money Laundering Settlement,” Law360 (May 25, 2017)
Prewitt, Elizabeth, Robert Bell and Dina Hoffer, “DOJ Narrows Paths To Immunity For Antitrust Crimes,” Law360 (Jan. 19, 2017)
Prewitt, Elizabeth, and Rosa M. Abrantes-Metz, “Antitrust Compliance 2.0: The Use of Structural Analysis and Empirical Screens to Detect Collusion and Corruption in Bidding Procurement Processes,” Competition Policy International (CPI) Antitrust Chronicle (2015)
Prewitt, Elizabeth, and Greta Fails, “Indirect Information Exchanges to Hub-and-Spoke Cartels: Enforcement and Litigation Trends in the United States and Europe,” Competition Law & Policy Debate 2 (2015) 63
Moderator, ABA Antitrust Section, “Ears Burning? Information Sharing in Cartel Investigations,” Webinar, Sept. 13, 2017
Speaker, IBA 21st Annual Competition Conference, “Protecting documents: confidentiality, publication, disclosure and legal privilege,” Florence, Italy, Sept. 9, 2017
Panelist, National Association of Criminal Defense Lawyers’ 12th Annual White Collar Seminar, “Defending the White Collar Case: In & Out of Court,” Conference, Washington, DC, October 26-28, 2016.
Speaker, NYSBA International Section, “Developments in Victim Recovery Litigation,” Panel, Paris, France, October 20, 2016.
Speaker, ABA Antitrust Section, “Exploring Antitrust Law: Perspectives from US and International Practitioners,” Panel, New York, NY, October 18, 2016
Panelist, MLEX Competition Litigation Conference, “International Developments in Antitrust Litigation,” Panel, London, England, September 28, 2016.
Faculty, National Institute on Internal Corporate Investigations and Forum for In-House Counsel, Washington, DC, April 27 – 29, 2016
Faculty, ABA Antitrust Section, “International Cartel Workshop,” Conference, Tokyo, Japan, Feb. 3 – 5, 2016
Speaker, New York State Bar Association (NYSBA) Antitrust Section, “Financial Benchmarks, Competition and Antitrust Injury: Untying the Knot,” Conference, New York, Jan. 28, 2016
Faculty, ABA Antitrust Section, Next Generation of Antitrust Scholars, Conference, New York, Jan. 22, 2016
Panelist, ABA Antitrust Section, “Know Your Antitrust Audience: Agency Advocacy vs. Litigation,” Panel, Jan. 16, 2016
Moderator, American Bar Association, “Cartel Facilitators: When Vertical Conduct Crosses over to Horizontal Liability,” Webinar, Nov. 30, 2015
Panelist, C5’s Fourth Miami Forum on Fraud, Asset Tracing & Recovery, “Managing Ethical Considerations in Fraud Litigation,” Miami, Oct. 27, 2015
Moderator, TASA: TRACE Anti-Bribery Specialist Accreditation, “The Antitrust and Anti-Corruption Connection: Bid Rigging in Procurement,” Webinar, Oct. 14, 2015
Panelist, Debate on ‘A-typical Cartels,’ Brussels, Oct. 2, 2015
Panelist, ABA Antitrust Section, “Conducting Antitrust Audits as Part of an Effective Compliance Program,” Webinar, Sept. 29, 2015
Panelist, ABA’s Business Law Section Annual Meeting, “Hot Issues in Compliance – What You Need to Know to Stay Out of the Government’s Crosshairs,” Chicago, Sept. 19, 2015
Moderator, ABA Antitrust Section, “Global to Local and Back Again: Perspectives and Practices from the Front Lines of Compliance in Emerging Markets,” June 30, 2015
Speaker, NYSBA White-Collar Criminal Litigation Meeting, June 17, 2015
Moderator, American Conference Institute (ACI), Women Leaders in Financial Services Law, New York, June 16, 2015
Panelist, International Bar Association, 18th Annual Transnational Crime Conference, Global Criminal Antitrust and FCPA Enforcement: “Moving in Tandem or Each Dancing to Their Own Tune?,” Berlin, May 7, 2015
Panelist, ABA Antitrust Section Spring Meeting, “Next Generation Cartels: New Tools for Enforcers’ Toolkits?,” Washington, DC, April 15, 2015
Speaker, GCM Parker, Sixth Annual Business Ethics, Anti-Corruption & Fraud Prevention Strategies in CEE, SEE & CIS: “Mitigating Corruption Risks in Joint-Ventures & Consortia,” Prague, March 26, 2015
Faculty, Practising Law Institute, “Fundamentals of Taking and Defending Depositions,” New York, March 19, 2015
Keynote Speaker, Women’s Competition Network Event, “A View from Both Sides of the Atlantic,” Brussels, Feb. 24, 2015
Representing a foreign manufacturer in a DOJ cross-border e-commerce price fixing investigation.
Representing a U.S. financial institution and its foreign affiliate in cross-border DOJ and regulatory investigations of manipulation in bond markets.
Representing a U.S. pharmaceutical company facing a DOJ antitrust cartel investigation in the generic pharmaceutical industry.
Representing a foreign financial institution facing U.S. regulatory investigations relating to trading practices.
Representing a European branded pharmaceutical company facing multiple states Attorneys General antitrust investigations.